Skip to main content
Year archive

Medivir — 2020 filings

All 28 regulatory filings released by Medivir (MVIR) in 2020, sourced directly from the official regulator.

28 Filings
2020 Period
2020 filings (28)
Filing Released Lang
Medivir stärker förutsättningarna för affärsutveckling genom omförhandlat avtal med TetraLogic avseende birinapant
Regulatory Filings
2020-12-11 Swedish
Medivir strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant
Regulatory Filings
2020-12-11 English
Notice of extraordinary general meeting of Medivir AB (publ)
AGM Information
2020-12-11 English
Kallelse till extra bolagsstämma i Medivir AB (publ)
AGM Information
2020-12-11 Swedish
MEDIVIR BESLUTAR OM FÖRETRÄDESEMISSION OM CIRKA 170 MSEK OCH ÖVERTILLDELNINGSOPTION MED STARKT STÖD FRÅN BEFINTLIGA OCH NYA SPECIALISTINVESTERARE
Capital/Financing Update
2020-12-11 Swedish
MEDIVIR RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 170 MILLION AND AN OVER-ALLOTMENT OPTION WITH STRONG SUPPORT FROM EXISTING AND NEW SPECIALIST INVESTORS
Capital/Financing Update
2020-12-11 English
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-10 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report 9M 2020
2020-11-10 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H2 2020
2020-08-20 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-08-20 English
Medivir utser Yilmaz Mahshid till ny VD
Board/Management Information
2020-05-26 Swedish
Medivir appoints Yilmaz Mahshid as new CEO
Board/Management Information
2020-05-26 English
FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma
Regulatory Filings
2020-05-06 English
FDA beviljar MIV-818 som särläkemedel för behandling av hepatocellulär cancer
Regulatory Filings
2020-05-06 Swedish
Beslut vid årsstämma i Medivir den 5 maj 2020
AGM Information
2020-05-05 Swedish
Resolutions at the Annual General Meeting in Medivir on 5 May 2020
AGM Information
2020-05-05 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-05 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-05 English
Annual Report 2019
Annual Report FY 2019
2020-04-06 Swedish
Annual Report 2019
Annual Report FY 2019
2020-04-06 English
Kallelse till årsstämma i Medivir AB (publ)
AGM Information
2020-04-06 Swedish
Notice of Annual General Meeting of Medivir AB (publ)
AGM Information
2020-04-06 English
Första patienten med levercancer doserad i Medivirs fas Ib-studie med MIV-818
Regulatory Filings
2020-03-10 Swedish
First liver cancer patient dosed in the MIV-818 phase Ib study
Regulatory Filings
2020-03-10 English
Medivir presents positive data from the completed phase Ia study with MIV-818 in patients with advanced liver cancer
Regulatory Filings
2020-03-02 English
Medivir presenterar positiva data från den avslutade fas Ia-studien med MIV-818 i patienter med avancerad levercancer
Earnings Release FY 2020
2020-03-02 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-13 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report FY 2019
2020-02-13 English